Characterization of phytoplankton productivity and bio-optical variability in a polar marine ecosystem

Knowledge of Southern Ocean carbon cycling is limited by a paucity of phytoplankton primary productivity (PP) and spectral absorption data in this globally-important region. We measured 13C-based PP in the Indian sector of Southern Ocean (ISSO) during austral summer 2017, examining its link with spectral absorption coefficients and phytoplankton size structure derived from an absorption-based global model. Phytoplankton productivity was assessed at both coastal (60°S-69°S) and frontal stations (40°S-60°S), characterized by silicate- replete and -deplete water masses, respectively (indicated by measured nutrient ratios) to capture a range of phytoplankton growth conditions. Bio-optical relationships were used as indicators of phytoplankton community size structure and to assess the extent of cellular pigment packaging - a phenomenon reported previously for phytoplankton in this region. Blue-Red (B/R) ratios of phytoplankton absorption (aph) spectra indicated that microphytoplankton (more prone to “package effects”) were the dominant size class at most sites sampled. Overall, PP was better explained by aph (R2 = 0.85) than total chlorophyll-a (R2 = 0.64) in surface waters. The a*ph (675)-chlorophyll-a relationship explained package effects more effectively in frontal regions (R2 = 0.63) than stations further south (R2 = 0.30). The global absorption-based model captured smaller (pico, nano) phytoplankton size classes but failed to identify larger microphytoplankton, underscoring the need for region-specific algorithm modifications. Our findings improve existing understanding of spatio-temporal trends in PP and bio-optical variability within the Indian Sector of the Southern Ocean (ISSO) – knowledge that is essential to improve capacity to retrieve PP from satellite-based models in this region

Cancer prevention and therapy through the modulation of the tumor microenvironment

Cancer arises in the context of an in vivo tumor microenvironment. This microenvironment is both a cause and consequence of tumorigenesis. Tumor and host cells co-evolve dynamically through indirect and direct cellular interactions, eliciting multiscale effects on many biological programs, including cellular proliferation, growth, and metabolism, as well as angiogenesis and hypoxia and innate and adaptive immunity. Here we highlight specific biological processes that could be exploited as targets for the prevention and therapy of cancer. Specifically, we describe how inhibition of targets such as cholesterol synthesis and metabolites, reactive oxygen species and hypoxia, macrophage activation and conversion, indoleamine 2,3-dioxygenase regulation of dendritic cells, vascular endothelial growth factor regulation of angiogenesis, fibrosis inhibition, endoglin, and Janus kinase signaling emerge as examples of important potential nexuses in the regulation of tumorigenesis and the tumor microenvironment that can be targeted. We have also identified therapeutic agents as approaches, in particular natural products such as berberine, resveratrol, onionin A, epigallocatechin gallate, genistein, curcumin, naringenin, desoxyrhapontigenin, piperine, and zerumbone, that may warrant further investigation to target the tumor microenvironment for the treatment and/or prevention of cancer